Nordic Pharma Lab ApS: Financial statements 2024
CVR: 39161672
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -18,918 and a net result of DKK -30,573 compared with DKK -28,302 the year before. Equity in the 2024 report amounted to DKK -318,510.
- Gross Profit
- DKK -18,918
- Profit/Loss
- DKK -30,573
- Equity
- DKK -318,510
- Total Assets
- DKK 5,269
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -19 t. | -31 t. | -319 t. | - |
| 2023 | - | -19 t. | -28 t. | -288 t. | - |
| 2022 | - | -24 t. | -33 t. | -260 t. | - |
| 2021 | - | -106 t. | -283 t. | -226 t. | - |
| 2020 | 1 | -41 t. | -20 t. | 57 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Nordic Pharma Lab ApS has published its annual report for 2023. Gross profit came to DKK -18,791, and the net result was DKK -28,302.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity in the 2025 report amounted to DKK -429,426.